HMG-CoA reductase inhibitor, especially atorvastatin, could act as a suitable therapy for essential hypertension in elderly patients, and and JAK/STAT inhibition might be promising in patients with hypertension. This evidence concerns the gene SOAT1 and essential hypertension.